BioLASCO Taiwan Co. Ltd. Statistics
BioLASCO Taiwan Co. Ltd. (6662) Stock Statistics & Valuation Metrics
Total Valuation
BioLASCO Taiwan Co. Ltd. has a market cap or net worth of TWD 727.39M. The enterprise value is TWD 711.75M.
- Market Cap
- TWD 727.39M
- Enterprise Value
- TWD 711.75M
Share Statistics
BioLASCO Taiwan Co. Ltd. has 25,612,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,612,400
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BioLASCO Taiwan Co. Ltd.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.45%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 7.45%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 2.89M
- Profits Per Employee
- 466.24K
- Employee Count
- 91
- Asset Turnover
- 0.44
- Inventory Turnover
- 5.34
Valuation Ratios
The current PE Ratio of BioLASCO Taiwan Co. Ltd. is 17.75. BioLASCO Taiwan Co. Ltd.’s PEG ratio is -1.16.
- PE Ratio
- 17.75
- PS Ratio
- 2.82
- PB Ratio
- 1.68
- Price to FCF
- 21.56
- Price to Operating Cash Flow
- 16.39
- PEG Ratio
- -1.16
Income Statement
In the last 12 months, BioLASCO Taiwan Co. Ltd. had revenue of 262.66M and earned 42.43M in profits. Earnings per share was 1.66.
- Revenue
- 262.66M
- Gross Profit
- 101.62M
- Operating Income
- 48.04M
- Pretax Income
- 49.56M
- Net Income
- 42.43M
- EBITDA
- 59.58M
- Earnings Per Share (EPS)
- 1.66
Cash Flow
In the last 12 months, operating cash flow was 43.89M and capital expenditures -10.15M, giving a free cash flow of 33.73M billion.
- Operating Cash Flow
- 43.89M
- Free Cash Flow
- 33.73M
- Free Cash Flow per Share
- 1.33
Dividends & Yields
BioLASCO Taiwan Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.46%
- Dividend Per Share
- ―
- Dividend Yield
- 5.46%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.64%
- Earnings Yield
- 5.69%
Stock Price Statistics
- Beta
- -0.03
- 52-Week Price Change
- -8.09%
- 50-Day Moving Average
- 28.50
- 200-Day Moving Average
- 28.33
- Relative Strength Index (RSI)
- 49.68
- Average Volume (3m)
- 4,431
Important Dates
BioLASCO Taiwan Co. Ltd. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
BioLASCO Taiwan Co. Ltd. as a current ratio of 3.93, with Debt / Equity ratio of 20.45%
- Current Ratio
- 3.93
- Quick Ratio
- 3.37
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- 0.22
- Interest Coverage Ratio
- 23.64
Taxes
In the past 12 months, BioLASCO Taiwan Co. Ltd. has paid 7.14M in taxes.
- Income Tax
- 7.14M
- Effective Tax Rate
- 0.14
Enterprise Valuation
BioLASCO Taiwan Co. Ltd. EV to EBITDA ratio is 12.64, with an EV/FCF ratio of 21.61.
- EV to Sales
- 2.82
- EV to EBITDA
- 12.64
- EV to Free Cash Flow
- 21.61
- EV to Operating Cash Flow
- 16.61
Balance Sheet
BioLASCO Taiwan Co. Ltd. has TWD 141.27M in cash and marketable securities with TWD 87.01M in debt, giving a net cash position of TWD 54.26M billion.
- Cash & Marketable Securities
- TWD 141.27M
- Total Debt
- TWD 87.01M
- Net Cash
- TWD 54.26M
- Net Cash Per Share
- TWD 2.12
- Tangible Book Value Per Share
- TWD 16.87
Margins
Gross margin is 38.95%, with operating margin of 17.79%, and net profit margin of 15.85%.
- Gross Margin
- 38.95%
- Operating Margin
- 17.79%
- Pretax Margin
- 18.53%
- Net Profit Margin
- 15.85%
- EBITDA Margin
- 22.35%
- EBIT Margin
- 17.36%
Analyst Forecast
The average price target for BioLASCO Taiwan Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -8.71%
- EPS Growth Forecast
- -16.08%
